AI in Oncology Market Expanding Rapidly with AI-Powered Screening and Diagnostic Tools | Key players: Azra Al, Cure Metrix, Inc., Concert AI, Immunai

The global AI in oncology market size reached US$ 2.43 Billion in 2024 and is expected to reach US$ 22.85 Billion by 2033, growing at a CAGR of 25.3% during the forecast period 2025-2033.

AI in Oncology Market is set to expand significantly over the next few years, according to the latest market intelligence report. This comprehensive study analyzes emerging trends, market size, pricing dynamics, and strategic opportunities, empowering B2B marketers, analysts, and industry stakeholders with critical data for informed decision-making.

Get exclusive insights - Request your sample report now @ https://datamintelligence.com/download-sample/ai-in-oncology-market?sp

AI in oncology refers to the application of artificial intelligence technologie such as machine learning, natural language processing, and computer vision to detect, diagnose, and treat cancer more accurately and efficiently. These solutions help analyze medical images, predict treatment outcomes, identify genetic markers, and personalize cancer therapies.

Market Players in the AI in Oncology market
The prominent players in AI in Oncology market research report are:

Azra Al, CureMetrix, Inc., ConcertAI, Immunai, MVision AI Inc., Paige AI, Inc., Mindpeak GmbH, Imagene AI Ltd., Predictive Oncology, Tempus, among others.
The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.

AI in Oncology Market Key Development:

✅In 2025, the AI in oncology market is gaining momentum due to rising cancer incidence, the push for precision medicine, and growing healthcare digitization.

✅In February 2025, Avitia announced its business launch and $5M seed investment from PacBridge Capital Partners ("PacBridge"). With Avitia's platform, laboratories and clinicians now have access to advanced molecular testing directly on-site. This technology will allow a healthcare team to accurately obtain cancer insights and begin treating patients faster, all at reduced costs compared to existing send-out alternatives.

Speak to Our Senior Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/ai-in-oncology-market?sp

AI in Oncology Market Segments :

✒︎By Component Type: Software, Hardware, Services

✒︎By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Skin Cancer, Others

✒︎By Application: Cancer Detection, Drug Discovery, Drug Development, Others

The AI in Oncology industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.

Research Methodology:
Our analytical framework employs cutting-edge statistical modeling and data mining techniques to identify emerging patterns, forecast market trajectories, and decode complex industry dynamics. We enhance our findings through sophisticated market segmentation analysis and Porter's Five Forces evaluation, providing a 360-degree view of the competitive landscape. This multi-layered methodology ensures our delivered insights are not only data-driven and credible but also strategically relevant and immediately actionable for critical business decisions.

Regions Covered:
The global AI in Oncology Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
☞ North America - US, Canada, Mexico
☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe
☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific
☞ South America- Brazil, Argentina, Colombia, Rest of South America
☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel

This Report Covers:
✔ Go-to-market Strategy.
✔ Neutral perspective on the market performance.
✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, Market Access, and other significant analysis, as well as development status.
✔Customized regional/country reports as per request and country level analysis.
✔ Potential & niche segments and regions exhibiting promising growth covered.
✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Buy Now & Unlock 360° Market Intelligence:
https://www.datamintelligence.com/buy-now-page?report=ai-in-oncology-market?sp

Purchase Industry Subscription Today - Make Smarter Decisions Tomorrow:
Purchase Your Subscription to Power Your Strategy with Precision: https://www.datamintelligence.com/reports-subscription

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.